baber/WOPTO huggingface dataset:
Patent NZ-526584-A (NZ)
Title: Method and device for handling telephone calls directed to non-reachable mobile phones
Inventor: MURRI PAOLO
IPC: H04M3/42
Filed: 2001-12-11
Abstract: A method for handling telephone call from a calling subscriber a radio mobile phone of a called subscriber comprises: I- determining if the called subscriber is not reachable , due to the mobile phone being in detach mode or due to absence of a radio frequency signal , and if a call diversion device towards an answering service or another phone number is not operative; II- In the affirmative case, routing the telephone call from a switching node to a device for storage and management of data relating to the telephone call; III- extracting the telephone number of the calling subscriber from the signalling component of the routed telephone call, and recording in a number list the telephone number and hour/date of the telephone call; IV- emitting a deliver message to the switching node, in order to allow the switching node to release the phonic channel of the telephone call; V- determining of the mobile phone of the called subscriber is reachable again; VI - in the affirmative case, sending a message comprising the telephone number and the hour/date of the telephone call to a SMS service centre; VII- transmitting from the SMS service centre to the mobile phone of the called subscriber, a SMS message including the telephone number and the hour/date of the telephone call.
Patent NZ-528789-A (NZ)
Title: A method and apparatus for monitoring attendance
Inventor: ELLER MICHAEL JOSEPH
IPC: G07C1/20
Filed: 2002-03-28
Abstract: A system for monitoring attendance that comprises:- (a) A series of stationary identification devices located at spaced locations within a predetermined monitoring area; (b) A plurality of discrete units for detecting attendance of the units at the identification devices, each of the discrete units including both a transmitter and receiver; and (c) A server including a timer associated with at least one conformance parameter and a transmitter and receiver to respectively transmit data to, and receive data from, the plurality of discrete units. The server receives data from the discrete units when an identification device has been detected, when the attendance of one or more identification devices has not been detected by a first discrete unit and transmitted to the server within a time limit determined by at least one conformance parameter, the server transmits data to alert at least a second discrete unit.
Patent NZ-542286-A (NZ)
Title: A method of forming biomimetic membranes
Inventor: PHUNG HONG THAI
Filed: 2005-09-07
Abstract: Disclosed are methods of preparing a bilayer lipid membrane on a support matrix as well as a matrix preloaded with a protein and methods to achieve same. Steps used include hydration, pore infiltration, application of bilayer lipid membrane forming solutions and application of protein containing solutions. The methods and matrix produced are able to form and maintain a stable membrane. A further advantage is that the matrix may be pre-loaded with protein and then stored for use at a later date effectively stabilising the protein for later use.
Patent NZ-548123-A (NZ)
Title: O-linked glycosylation of peptides
Inventor: DEFREES SHAWN
IPC: A61K38/19
Filed: 2005-01-10
Abstract: Provided is an isolated G-CSF polypeptide comprising an O-linked glycosylation site that does not exist in wildtype sequence, wherein said isolated G-CSF polypeptide comprises a peptide sequence having the formula of M1XnTPLGP or M1BoPZmXnTPLGP, wherein the superscript denotes the corresponding position of the amino acid in wildtype, and the subscripts n and m are integers selected from 0 to 3; at least one of X and B is Thr or Ser, and when more than one of X and B is Thr or Ser, the identity of these moieties is independently selected; and Z is selected from glutamate, or any uncharged amino acid. Further provided are corresponding nucleic acids and methods of making glycoconjugates of said peptides as well as using the peptides for G-CSF therapy.
Patent NZ-553858-A (NZ)
Title: Metabolically active micro organisms and methods for their production
Inventor: THURLBY TIMOTHY
IPC: A23L11/20
Filed: 2005-09-27
Abstract: Provided is a preparation comprising viable, metabolically active bacteria and a growth substrate comprising a mixture of complex and simple sugars, wherein the total amount of sugars is in the range of from 20 mg/ml to 40 mg/ml and wherein the total amount of reducing sugars is in the range of from 5 mg/ml to 20 mg/ml, proteins and peptides, wherein the bacteria in the preparation exhibit a near equilibrium growth state characterised in that the population of bacteria is maintained at a constant level when stored at about 4°C and at controlled pH for a period of at least 5 months. Further provided are methods of producing such preparations and use of the preparations in the manufacture or a medicament for treatment of intestinal disorders.
Patent NZ-554126-A (NZ)
Title: Methods for rapid production and usage of biogenerated flavors for cheese
Inventor: GALER CHAD D
IPC: A23L27/20
Filed: 2007-03-26
Abstract: Disclosed is a method for preparing a flavour component, said method comprising: preparing a first mixture comprising about 1to about 8 percent protein, about 25 to about 70 percent fat, about 0.01 to about 2 percent sulfur-containing substrate, about 2 to about 15 percent salt, and a bacteriocin source, wherein the first mixture has a pH of about 5 to about 9; heating the first mixture at a temperature and time effective for sterilizing the first mixture; cooling the heated first mixture to about 20 to about 30·C; treating the cooled first mixture with a bacteriocin-resistant culture to form a second mixture, whereby the bacteriocin-resistant culture is effective for converting the sulfur-containing substrate to sulfur-containing flavour compounds; and treating the second mixture at a temperature sufficient to inactivate the culture in the second mixture to form the flavour component.
Patent NZ-554824-A (NZ)
Title: Porcines that lack endogenous antibody chains and express exogenous immunoglobulins
Inventor: WELLS KEVIN
IPC: A01K67/00
Filed: 2005-10-24
Abstract: Disclosed is a transgenic ungulate porcine that lacks any expression of functional endogenous heavy chain, kappa light chain, and lambda light chain immunoglobulins. The porcine may be further modified to express exogenous immunoglobulin loci.
Patent NZ-556134-A (NZ)
Title: System and method for gaming based upon intermediate points in a race event
Inventor: AMAITIS LEE M
IPC: A63F1/04
Filed: 2005-12-22
Abstract: A gaming system, comprises a memory operable to store an identification of a particular race participant in a race event having a plurality of race participants; and a processor coupled to the memory and operable to: determine a particular position of the particular race participant at each of a plurality of intermediate points within the race event; determine a plurality of simulated playing cards based at least in part upon the determined positions of the particular race participant; and determine an outcome of a game based at least in part upon the determined simulated playing cards.
Patent NZ-566029-A (NZ)
Title: Vitamin D derivatives for the treatment of type I diabetes
Inventor: DELUCA HECTOR F
IPC: A61K31/592
Filed: 2006-09-19
Abstract: Disclosed is a use of a vitamin D compound in the manufacture of a medicament for delaying the onset of Type I diabetes in a human patient, wherein the medicament is formulated for oral administration and the medicament is to be administered after the appearance and detection of at least two autoantibodies indicative of Type I diabetes and before the patient develops blood sugar of 150 mg/dL, measured as an average of 5 samples taken throughout the day at least 2 hours apart, whereby the onset of Type I diabetes or Type I diabetes symptoms is slowed.
Patent NZ-567259-A (NZ)
Title: Methods of making snack food products and products made thereby
Inventor: ASHOURIAN JAMSHID
IPC: A23L19/18
Filed: 2006-10-04
Abstract: A method of making a snack food product comprises providing a plurality of cut or shaped food pieces, blanching the plurality of food pieces for a time sufficient to inactivate any enzymes on the surface of the food pieces, and then reducing the moisture level of the food pieces to about 0.5 to about 10% by weight.
Patent NZ-569700-A (NZ)
Title: Polymer formulations of CETP inhibitors
Inventor: GEERS SARAH
IPC: A61K9/20
Filed: 2007-02-09
Abstract: Disclosed herein are pharmaceutical compositions comprising: a) a CETP inhibiting oxazolidinone compound of formula Ii, or a pharmaceutically acceptable salt thereof wherein the substituents are as defined within the specification; b) a concentration-enhancing polymer selected from the group consisting of hydroxypropyl methyl cellulose acetate succinate (HPMCAS), hydroxypropyl methyl cellulose phthalate (HPMCP), cellulose acetate phthalate (CAP), cellulose acetate trimellitate (CAT), methyl cellulose acetate phthalate, hydroxypropyl cellulose acetate phthalate, cellulose acetate terephthalate, cellulose acetate isophthalate, polyvinylpyrrolidinone, and polyvinylpyrrolidinone-polyvinylacttate copolymers; and c) optionally one or more surfactants selected from the group consisting of sodium dodecyl sulphate and one or more noninoic surfactants selected from a)sorbitan fatty acid esters, b) polyoxyethylene sorbitan fatty acid esters, c) polyoxyethylene castor oils, d) polyoxyethylene hydrogenated castor oils, and e) vitamin E TPGS; and mixtures thereof. Such compositions are useful in raising HDL-cholesterol in a patient.
Patent NZ-573644-A (NZ)
Title: Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
Inventor: BALLELL LLUIS
IPC: C07D497/04
Filed: 2007-07-18
Abstract: Disclosed herein are n-ethylquinolone and n-ethylazaquinolone derivatives of formula (I) wherein A is non-aromatic nitrogen containing heterocyclic moiety, R5 is a pyrimidine heterocyclic substituent and the other substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and the use of the compounds in the treatment of bacterial infections.
Patent NZ-577252-A (NZ)
Title: Mobile concentration system and method
Inventor: SMITH ANDREW
IPC: A01J11/06
Filed: 2007-01-18
Abstract: A mobile concentration system (MCS) for milk 100 comprising (a) a vehicle having at least one holding tank for receiving and holding milk 116 and 118, and (b) a concentration system 100 mounted to the vehicle and coupled in fluid communication with the holding tank 116, the concentration system 100 adapted to remove milk from the holding tank 116 and process the milk while the vehicle is stationary and/or uploading or unloading of milk, or underway, the concentration system including a reverse osmosis filtration system 106 adapted receive the milk from the holding tank 116 and process the milk. to generate a stream of substantially water 132·and a product stream of concentrated milk· 110, leading to another holding tank or the same holding tank, (c) the concentration system including, (d) Feed section comprising product/water/CIP (clean in place) valving systems, high pressure pumping equipment 124 operating to receive and pressurize the milk through-out the system, (e) Concentration level control system comprising a control valve regulating the concentrate flow 110 to achieve a fixed system operating pressure to control the system.
Patent NZ-577466-A (NZ)
Title: Assembly of baffles and seals and method of assembling a heat exchanger
Inventor: MULDER DOMINICUS FREDERICUS
IPC: F28F9/22
Filed: 2007-12-12
Abstract: Disclosed is an assembly of baffles and seals for mounting in a cylindrical heat exchanger shell. The assembly comprises a plurality of longitudinal baffles which subdivide the interior of the shell into separate longitudinally extending compartments and at least one longitudinal seal. The assembly further comprises a wall member that is arranged to extend between spaced apart longitudinal baffles so as to form a double wall with the heat exchanger shell after mounting. The at least one longitudinal seal is arranged on the wall member and away from the longitudinal baffles so as to sealingly engage the wall member against the heat exchanger shell after mounting.
Patent NZ-577820-A (NZ)
Title: Fluidized spray drying of vx-950 (telaprevir)
Inventor: GASPAR FILIPE
IPC: A61K38/05
Filed: 2007-12-26
Abstract: Disclosed is a method of fluidized spray drying VX -950, otherwise known as Teleprevir, the method comprising: preparing a liquid feed solution comprising VX-950; atomizing the feed solution upon delivery into the drying chamber of a spray dryer operating in fluidized spray drying mode; drying the feed solution in the drying chamber with heated air or a heated gas to obtain a product, wherein larger particles of product separate out, while fines are carried by a stream of air or gas up to the top of the drying chamber and to a cyclone, and re-introducing the fines into the drying chamber, wherein the re-introduced fines can agglomerate with newly formed product to generate an agglomerated product, wherein if the agglomerated product is large enough, it will separate out, if it is not large enough to separate out, the agglomerated product will be carried by convection to the top of the chamber and to the cyclone and re-introduced into the chamber.
Patent NZ-578388-A (NZ)
Title: Road signage base with pivoting legs and rotation prevention socket for post
Inventor: BREWIN PAUL GREGORY
IPC: E01F9/70
Filed: 2007-08-16
Abstract: A base for a road sign post includes a tubular member or socket 11 to receive the lower end of the post and at least three legs 13 to 16 arrayed out from the socket to support the socket in an upright position. At least two of the legs 14 to 16 are pivotally mounted on a support feature 14A, 16A depending from the socket and enable the base whilst supporting a post to be knocked over so that the socket is no longer upright. The socket interior surface is generally cylindrical to receive the post but includes an adaptation, such as a cornered plug or aperture, for indexing the complementary lower end of the post to prevent rotation of the post about its longitudinal axis relative to the socket.
Patent NZ-583267-A (NZ)
Title: Fused bicyclic pyrimidines
Inventor: HOLDER SWEN
IPC: C07D487/04
Filed: 2008-08-14
Abstract: Disclosed are fused pyrimidine compounds, salts, tautomers, and stereoisomers of formula (I), wherein the substituents are as described within the specification. Examples of compounds of formula (I) include: 6-phenyl-7-(4-{ [4-(3-pyridin-2-yl-1,2,4-triazol-5-yl)piperidin-1-yl]methyl} phenyl)imidazo[1,2a]-pyrimidine; and Ethyl-6-phenyl-7-(4-{ [4-(5-pyridin-2-yl-1,2,4-triazol-3-yl)piperidin-1- yl]methyl} phenyl)imidazo[1,2-a]pyrimidine-2-carboxylate. Further disclosed is a pharmaceutical composition comprising at least one compound of formula (I), and a combination comprising one or more compounds of formula (I) and one or more second active agents selected from chemotherapeutic anti-cancer agents and target anti-cancer agents. Also disclosed is the of a compound of formula (I) for the production of a pharmaceutical composition for the treatment, prevention or amelioration of a disease mediated by a dysregulated function of a single protein kinase or multiple protein kinases and/or disorders responsive to the induction of apoptosis, and the treatment of benign and/or malignant neoplasia and cancer.
Patent NZ-595437-A (NZ)
Title: Short-chain peptides as parathyroid hormone (pth) receptor agonist
Inventor: BAHEKAR RAJESH
IPC: A61K38/29
Filed: 2010-04-26
Abstract: 595437 Disclosed is an isolated short chain peptide as defined herein, the short chain peptide is a parathyroid hormone receptor agonist with at least a non-natural amino acid at position 14 which enhances the duration of action and/or stability of the peptide against proteolytic enzymes.
Patent NZ-599040-A (NZ)
Title: 2,4-disubstituted pyrido[4,3-d]pyrimidin-5(6h)-one compounds for selective inhibitors of lrrk2 and syk kinases
Inventor: CHOI JANG-SIK
IPC: A61K31/4375
Filed: 2010-10-29
Abstract: Disclosed are 2-(piperidin-1-yl)-4-amino-pyrido[4,3-d]pyrimidine-5(6H)-one and 2-(benzylamino)-4-amino-pyrido[4,3-d]pyrimidine-5(6H)-one derivatives as represented by the general formula (I), wherein: R1 is H; X is NR2R3 or NR4R5; Y is NHR6; Z is selected from H, halogen, alkyl, alkynyl, aryl, heteroaryl, or cycloalkyl, wherein the alkyl, cycloalkyl, aryl, alkynyl or heteroaryl is optionally substituted; R2 and R3, taken together with the nitrogen atom to which they are bonded form: i) a 3-8 membered saturated or partially unsaturated monocyclic group having no heteroatom other than the nitrogen atom to which R2 and R3 are bonded, wherein said 3-8 membered saturated or partially unsaturated monocyclic group is substituted at one or more carbon atoms with 1-2 R7; or ii) an 8-10 membered bicyclic aryl group having 0-5 heteroatoms independently selected from nitrogen, oxygen, sulfur, sulfoxide, or sulfone; R4 is selected from H, alkyl, or hydroxyalkyl; R5 is arylalkyl, wherein the aryl group is independently substituted at one or more carbon atoms with 1-3 R11; R11 is independently selected from OR9, NR9R9, NR9COR9, or NR9S(O)nR9; R6 is selected from alkyl, alkenyl, alkynyl, cycloalkyl, heterocycloalkyl, cycloalkenyl, aryl, arylalkyl, or heteroaryl, wherein the heterocycloalkyl, aryl, or heteroaryl is optionally substituted; and wherein the remaining substituents are as defined herein. Representative compounds include 2-(4-hydroxypiperidin-1-yl)-4-(3-(trifluoromethyl)phenylamino)pyrido[4,3-d] pyrimidine-5(6H)-one and 2-(4-hydroxy-4-(hydroxymethyl)piperidin-1-yl)-4-(4-methoxy-3-(trifluromethyl) phenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one.
Patent NZ-599873-A (NZ)
Title: Integrated health data capture and analysis system
Inventor: MICHELSON SETH G
IPC: G16Z99/00
Filed: 2010-10-18
Abstract: Disclosed is a system for modelling a progression of a disease within a population. The system includes a plurality of point-of-care devices, each having a programmable processor. The system also includes an a static database, a dynamic database, a computer modelling component and external device configured to be in communication with the plurality of point-of-care devices. The static database includes static data related to the disease and/or the population and the dynamic database includes dynamic data about the population and individual subjects. The computer modeling component models the data in the static and dynamic databases, thereby modeling the disease within the population. The external device provides instructions to the programmable processor to implement a change in assay protocol based on output from the computer modeling component without having to provide new point-of-care devices. The instructions include at least a step of transferring bodily fluid sample to an individual assay unit (500).
Patent NZ-606429-A (NZ)
Title: Tackifiers for composite articles
Inventor: BOUGUETTAYA MOHAMED
IPC: B32B5/16
Filed: 2011-08-03
Abstract: Disclosed herein is a composite article comprising a plurality of lignocellulosic pieces and an adhesive system disposed on the plurality of lignocellulosic pieces for bonding the plurality of lignocellulosic pieces. The adhesive system comprises a binder component comprising an isocyanate componenet and a tackifier component comprising a styrene acrylic polymer for maintaining orientation of said plurality of lignocellulosic pieces during manufacture of said composite article. The composite article may be various engineered lignocellulosic composites, such as particleboard.
Patent NZ-609462-A (NZ)
Title: A bottle, mould and process
Inventor: ANDREW BERESFORD
IPC: C03B9/325
Filed: 2013-04-15
Abstract: A glass bottle that can be sealed using screw crown closure 22, the glass bottle including a finished upper portion on the neck of the bottle that is formed by a moulding apparatus having a pair of neck ring moulds and a guide plate. The finished upper portion of the bottle includes an outer wall that has a surface of a constant first diameter d1 on which a screw thread formation 23 extends about the outer wall, the screw thread formation 23 having a second diameter d2 that co-operates with a thread of the screw crown closure 22, the outer wall being moulded at least in part by the pair of neck ring moulds of the moulding apparatus, an end rim 24 that defines an opening and on which the crown closure 22 engages for sealing the bottle, the end rim 24 being moulded at least in part by the guide plate of the moulding apparatus, and a joining section 25 interconnecting the outer wall and the end rim, the joining section 25 having a circumferential seam 26 that is formed during the moulding process at the interface of the neck ring moulds and the guiding plate. The circumferential seam 26 has a third diameter d3 that is less than the first diameter d1 so that the circumferential seam 26 is located inward of the outer wall in a radial direction.
Patent NZ-623211-A (NZ)
Title: Container
Inventor: MORLEY RONALD EDWARD
IPC: G09F3/18
Filed: 2012-09-18
Abstract: A container with a label or indicia embedded in laminated polymer layers is described. The container (54) is suitable for holding food or beverages and the outer laminated layers are transparent so the label can be read. The laminated walls of the container comprise two polymer layers (38 and 40) e.g. polypropylene, with an intermediate layer of EVOH (46) which serves as a label and has a lower oxygen permeability to preserve the product. The label can also have an aperture (58) so that the two polymer laminates form a window for viewing the food product.
Patent NZ-703723-A (NZ)
Title: Combinations with a backbone-cyclized peptide
Inventor: OBRECHT DANIEL
IPC: C07K7/64
Filed: 2013-08-07
Abstract: A novel combination comprising a β-hairpin peptidomimetic of the formula cyclo(-Thr-Trp-Ile-Dab-Orn-DDab-Dab-Trp-Dab-Dab-Ala-Ser-DPro-Pro) (I), and a further compound with antibiotic activity, that enable therapeutic control of specific bacterial infections in human or animals at doses of the individual compounds lower than either of the compounds administered alone. The combination can be used as a medicament to treat e.g. skin or soft tissue infections; eye, ear, blood stream, or intra-abdominal infections; infections related to respiratory diseases, to bone diseases, to cardiovascular diseases, to genitourinal diseases, or to gastrointestinal diseases.
Patent NZ-723731-A (NZ)
Title: Reversing the effects of the tumor microenvironment using chimeric cytokine receptors
Inventor: LEEN ANN
IPC: C12N5/00
Filed: 2012-04-05
Abstract: An immune system cell comprising a chimeric cytokine receptor comprising a cytokine-binding exodomain and a signal transducing endodomain, wherein (a) the exodomain comprises an IL-13 cytokine binding exodomain and an IL-15 signal transducing endodomain. Further discloses treatment of cancer.
Patent NZ-724775-A (NZ)
Title: New medical agents and uses thereof
Inventor: LOSKOG ANGELICA
IPC: C07K14/705
Filed: 2015-04-07
Abstract: The invention provides a novel compounds derived from CD154, but without the intracellular domain. Notably, the invention provides TMZ-CD154 and a method to treat diseases in which the novel molecule TMZ-CD154 is used. In particular, TMZ-CD154 is used to modify the immune responses in patients with immune related diseases such as cancer and infectious disease. The invention also relates to a method to activate cells with the TMZ-CD154 in vitro either prior to using the activated cells for therapy or for diagnostic purposes.